Cardiac Autonomic Markers Partly Account for Adiposity‐Related Liver Enzyme Variation in Non‐Diabetic Adults With Overweight or Obesity
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.71238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Lu Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanj…. Hauptthemen laut MEDLINE: Obesity, Adiposity, Overweight, Liver. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
To quantify the extent to which cardiac autonomic markers account for the associations between adiposity and liver enzyme levels in non‐diabetic adults with overweight or obesity. Materials and Methods The clinical discovery cohort included 432 non‐diabetic adults with overweight or obesity. Body mass index (BMI) and waist‐to‐height ratio (WHtR) were exposures; alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma‐glutamyl transferase (GGT) were outcomes. Resting mean heart rate and heart rate variability (HRV) were assessed as cardiac autonomic markers. Multivariable regression and mediation analyses were performed. Supportive analyses included 21 383 UK Biobank participants.
Results
Higher BMI and WHtR were associated with higher liver enzyme levels, higher resting mean heart rate and lower HRV in the clinical cohort. Resting mean heart rate was the most consistent cardiac autonomic mediator, accounting for 16.6%–27.5% of the associations between BMI and liver enzyme levels and 17.8%–36.9% of those for WHtR. HRV indices accounted for 10.1%–28.2% and 8.8%–29.9% of the corresponding associations, respectively. After inclusion of the homeostatic model assessment of insulin resistance (HOMA‐IR) as a parallel mediator, indirect effects through cardiac autonomic markers remained statistically significant, particularly for ALT. In UK Biobank, resting pulse rate accounted for 5.83%–9.47% of the associations between adiposity and liver enzyme levels.
Conclusions
Higher resting heart rate and lower HRV partly accounted for cross‐sectional associations between adiposity and liver enzyme levels. Cardiac autonomic markers warrant further evaluation as complementary physiological measures in studies of obesity‐related liver enzyme variation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, China.
- Department of Endocrinology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
- Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Nanjing, China.
ORCID-Profile: Yan Bi
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gao, L., Guo, Y., Cong, X., Yang, T., Ma, H., Wu, T., Ge, Z., Zhang, P., & Bi, Y. (2026). Cardiac Autonomic Markers Partly Account for Adiposity‐Related Liver Enzyme Variation in Non‐Diabetic Adults With Overweight or Obesity. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71238
Vancouver
Gao L, Guo Y, Cong X, Yang T, Ma H, Wu T, et al. Cardiac Autonomic Markers Partly Account for Adiposity‐Related Liver Enzyme Variation in Non‐Diabetic Adults With Overweight or Obesity. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71238
BibTeX
@article{Gao2026,
author = {Gao, Lu and Guo, Yuxin and Cong, Xiangguo and Yang, Tongyue and Ma, Huayang and Wu, Tianyu and Ge, Zhijuan and Zhang, Pengzi and Bi, Yan},
title = {Cardiac Autonomic Markers Partly Account for Adiposity‐Related Liver Enzyme Variation in Non‐Diabetic Adults With Overweight or Obesity},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71238}
}
EUVIMED